Similar companies
Did MiNK Therapeutics Beat Earnings?
MiNK Therapeutics (INKT) reported Q2 '26 revenue of $0.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — MiNK Therapeutics’s job postings, web traffic, and employee business outlook. See the full INKT stock analysis or the earnings calendar for upcoming reports.
MiNK Therapeutics Quarterly Financial Trends
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | 3.77B | — | — | — | — | — | — |
| Gross margin | — | 0.0% | — | — | — | — | — | — |
| Operating margin | — | -0.1% | — | — | — | — | — | — |
| Net income | -1.8M | -2.5M | -2.8M | -4.2M | -2.9M | -2.6M | -2.7M | -3.1M |
| Net margin | — | -0.1% | — | — | — | — | — | — |
| EPS | — | — | — | — | — | — | — | — |
MiNK Therapeutics Earnings Trend Analysis
Over the eight quarters from Q3 '24 to Q2 '26, MiNK Therapeutics’s quarterly revenue moved from $0 to $0.
When Is MiNK Therapeutics’s Next Earnings Date?
MiNK Therapeutics reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the INKT earnings calendar.
Frequently Asked Questions: MiNK Therapeutics Earnings
MiNK Therapeutics's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
MiNK Therapeutics reported Q2 '26 revenue of $0.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the INKT AI Score.
